Location History:
- Groningen, NL (2012)
- Groningan, NL (2016)
Company Filing History:
Years Active: 2012-2016
Title: Maike Wubben: Innovator in Cell Culturing Technologies
Introduction
Maike Wubben is a prominent inventor based in Groningen, Netherlands. She has made significant contributions to the field of cell culturing, particularly through her innovative processes that enhance the efficiency and effectiveness of cell culture techniques. With a total of 2 patents, her work is paving the way for advancements in biotechnology.
Latest Patents
Maike Wubben's latest patents include two related inventions focused on the process for cell culturing by continuous perfusion. The first patent describes a method for culturing cells that involves the continuous addition of cell culture medium to a circulating cell culture. This process utilizes a filter module with hollow fibers, resulting in an outflow of liquid with a lower cell density than the original culture. The flow within the filter module is characterized by alternating tangential flow, which is particularly beneficial for aggregating cells. Additionally, this method allows for the production of biological substances, such as antibodies, which can be further purified in downstream processing.
The second patent mirrors the first, emphasizing the same innovative approach to cell culturing through continuous perfusion and alternating tangential flow. This dual focus on enhancing cell culture techniques showcases Maike's commitment to advancing biotechnological processes.
Career Highlights
Throughout her career, Maike Wubben has worked with notable companies, including Dpx Holdings B.V. and DSM IP Assets B.V. Her experience in these organizations has contributed to her expertise in the field of biotechnology and patent development.
Collaborations
Maike has collaborated with esteemed colleagues such as John Crowley and Jose Manuel Coco Martin. These partnerships have likely enriched her work and expanded the impact of her inventions.
Conclusion
Maike Wubben is a trailblazer in the realm of cell culturing technologies, with her innovative patents significantly contributing to the field. Her work not only enhances the efficiency of cell culture processes but also supports the production of valuable biological substances.